Cargando…
Investigating the value of radiomics stemming from DSC quantitative biomarkers in IDH mutation prediction in gliomas
OBJECTIVE: This study aims to assess the value of biomarker based radiomics to predict IDH mutation in gliomas. The patient cohort consists of 160 patients histopathologicaly proven of primary glioma (WHO grades 2–4) from 3 different centers. METHODS: To quantify the DSC perfusion signal two differe...
Autores principales: | Ioannidis, Georgios S., Pigott, Laura Elin, Iv, Michael, Surlan-Popovic, Katarina, Wintermark, Max, Bisdas, Sotirios, Marias, Kostas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690367/ https://www.ncbi.nlm.nih.gov/pubmed/38046592 http://dx.doi.org/10.3389/fneur.2023.1249452 |
Ejemplares similares
-
Multicenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
por: Manikis, Georgios C., et al.
Publicado: (2021) -
Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status
por: Sudre, Carole H., et al.
Publicado: (2020) -
The role of DSC MR perfusion in predicting IDH mutation and 1p19q codeletion status in gliomas: meta-analysis and technical considerations
por: Siakallis, Loizos, et al.
Publicado: (2023) -
Blood-brain barrier permeability imaging using perfusion computed tomography
por: Avsenik, Jernej, et al.
Publicado: (2015) -
Dynamic Susceptibility Contrast Enhanced (DSC) MRI Perfusion and Plasma Cytokine Levels in Patients after Tonic-clonic Seizures
por: Filipovic, Tatjana, et al.
Publicado: (2017)